Cargando…

Predicting survival time for metastatic castration resistant prostate cancer: An iterative imputation approach

In this paper, we present our winning method for survival time prediction in the 2015 Prostate Cancer DREAM Challenge, a recent crowdsourced competition focused on risk and survival time predictions for patients with metastatic castration-resistant prostate cancer (mCRPC). We are interested in using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Detian, Du, Yu, Ji, Zhicheng, Rao, Karthik, Wu, Zhenke, Zhu, Yuxin, Coley, R. Yates
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2016
Materias:	Method Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321124/ https://www.ncbi.nlm.nih.gov/pubmed/28299176 http://dx.doi.org/10.12688/f1000research.8628.1

Ejemplares similares

Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients
por: Pölsterl, Sebastian, et al.
Publicado: (2017)

Two-step feature selection for predicting survival time of patients with metastatic castrate resistant prostate cancer
por: Shiga, Motoki
Publicado: (2016)

A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer
por: Mahmoudian, Mehrad, et al.
Publicado: (2019)

Survival prognosis and variable selection: A case study for metastatic castrate resistant prostate cancer patients
por: Wengel Mogensen, Søren, et al.
Publicado: (2016)

mbImpute: an accurate and robust imputation method for microbiome data
por: Jiang, Ruochen, et al.
Publicado: (2021)

An ensemble-based Cox proportional hazards regression framework for predicting survival in metastatic castration-resistant prostate cancer (mCRPC) patients
por: Meier, Richard, et al.
Publicado: (2016)

The ENCODE Imputation Challenge: a critical assessment of methods for cross-cell type imputation of epigenomic profiles
por: Schreiber, Jacob, et al.
Publicado: (2023)

Genotype imputation via matrix completion
por: Chi, Eric C., et al.
Publicado: (2013)

DeepImpute: an accurate, fast, and scalable deep neural network method to impute single-cell RNA-seq data
por: Arisdakessian, Cédric, et al.
Publicado: (2019)

Towards accurate imputation of quantitative genetic interactions
por: Ulitsky, Igor, et al.
Publicado: (2009)

Melissa: Bayesian clustering and imputation of single-cell methylomes
por: Kapourani, Chantriolnt-Andreas, et al.
Publicado: (2019)

MIRTH: Metabolite Imputation via Rank-Transformation and Harmonization
por: Freeman, Benjamin A., et al.
Publicado: (2022)

Iterative epigenomic analyses in the same single cell
por: Ohnuki, Hidetaka, et al.
Publicado: (2021)

Accounting for missing data in statistical analyses: multiple imputation is not always the answer
por: Hughes, Rachael A, et al.
Publicado: (2019)

Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
por: Small, E J, et al.
Publicado: (2019)

Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Incidence rate estimation, periodic testing and the limitations of the mid-point imputation approach
por: Vandormael, Alain, et al.
Publicado: (2018)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Mai, Lixin, et al.
Publicado: (2020)

Statistical Methodological Issues in Handling of Fatty Acid Data: Percentage or Concentration, Imputation and Indices
por: Mocking, Roel J. T., et al.
Publicado: (2012)

SCRABBLE: single-cell RNA-seq imputation constrained by bulk RNA-seq data
por: Peng, Tao, et al.
Publicado: (2019)

TIGRA: A targeted iterative graph routing assembler for breakpoint assembly
por: Chen, Ken, et al.
Publicado: (2014)

Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies
por: Geeleher, Paul, et al.
Publicado: (2017)

VIPER: variability-preserving imputation for accurate gene expression recovery in single-cell RNA sequencing studies
por: Chen, Mengjie, et al.
Publicado: (2018)

Completing the ENCODE3 compendium yields accurate imputations across a variety of assays and human biosamples
por: Schreiber, Jacob, et al.
Publicado: (2020)

Impact of timing of radium‑223 administration on the survival of patients with bone metastatic castration‑resistant prostate cancer
por: Makita, Kenji, et al.
Publicado: (2023)

Improving draft assemblies by iterative mapping and assembly of short reads to eliminate gaps
por: Tsai, Isheng J, et al.
Publicado: (2010)

Genealogical inference and more flexible sequence clustering using iterative-PopPUNK
por: Zhao, Bin, et al.
Publicado: (2023)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
por: Vidal, Monica, et al.
Publicado: (2020)

Serum Chromogranin-A based Prognosis In Metastatic Castration Resistant Prostate Cancer
por: Giridhar, Karthik V., et al.
Publicado: (2018)

netNMF-sc: leveraging gene–gene interactions for imputation and dimensionality reduction in single-cell expression analysis
por: Elyanow, Rebecca, et al.
Publicado: (2020)

Structure-based discovery of selective CYP(17)A(1) inhibitors for Castration-resistant prostate cancer treatment
por: Omoboyowa, Damilola A, et al.
Publicado: (2021)

Optimization methods for the imputation of missing values in Educational Institutions Data
por: Aureli, D., et al.
Publicado: (2021)

TransLiG: a de novo transcriptome assembler that uses line graph iteration
por: Liu, Juntao, et al.
Publicado: (2019)

Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination Therapies
por: Wenzel, Mike, et al.
Publicado: (2021)

Radium-223 in metastatic castration resistant prostate cancer
por: Vuong, Winston, et al.
Publicado: (2014)

Treatment sequencing in metastatic castrate-resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2014)

Abiraterone in the treatment of metastatic castration-resistant prostate cancer
por: Mostaghel, Elahe A
Publicado: (2014)

Enzalutamide for patients with metastatic castration-resistant prostate cancer
por: Ramadan, Wijdan H, et al.
Publicado: (2015)

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
por: Rodriguez-Vida, Alejo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vdcfckkt3eedkme3miggk1phc6